Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 26,048 $ 3,926
Restricted cash 7,213 63
Accounts receivable, net 7,524 4,631
Inventories, net 3,424 4,869
Prepaid expenses and other current assets 3,726 4,074
Total Current Assets 47,935 17,563
Property and equipment, net 168 252
Right-of-use assets, operating leases 68 345
Intangible assets, net 11,968 13,115
Goodwill 18,614 18,614
Other assets 114 1,364
Total Assets 78,867 51,253
Current Liabilities    
Term loans, net 780 7,826
PPP loans 0 190
Accrued and other liabilities 1,607 3,400
Accounts payable 4,047 3,137
Operating lease liability 52 173
Warrant liability 0 39,850
Total Current Liabilities 6,486 54,576
Non-current Liabilities    
Notes payable, net 0 18,910
Term loans, net 4,779 0
Lines of credit, net 4,846 5,023
PPP loans 0 662
Operating lease liability 19 184
Total Non-current Liabilities 9,644 24,779
Total Liabilities 16,130 79,355
Stockholders’ Equity (Deficit)    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,241,317 and 8,651,400 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 29 9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, — shares and 21,754 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 0 0
Additional paid-in capital 316,554 232,530
Accumulated deficit (253,846) (260,641)
Total Stockholders’ Equity (Deficit) 62,737 (28,102)
Total Liabilities and Stockholders’ Equity (Deficit) $ 78,867 $ 51,253